Potter Clarkson is already actively engaged in a series of UPC revocation actions

ARTICLE SUMMARY

On 1 June 2023, the UPC agreement finally came into force.

authors
Related Services
Related Industries

On 1 June 2023, the UPC agreement finally came into force.

While this was the conclusion of our race to take and action our clients’ instructions as to whether to opt-out of the UPC, less than two weeks into the life of the court we have already been catapulted into the heart of yet another enormous project.

Now that the court is live, any patent granted by the EPO that is nationally validated in the UPC territories and not opted-out of its jurisdiction can be attacked centrally in a UPC revocation action.

If such a claim is successful, it will be revoked across all 17 countries currently participating in the UPC in a single but highly effective action.

Many of our clients are already alive to the benefits of launching such actions. We have already filed a number of actions at the UPC, and we are receiving more enquires from our clients every day.

We will very shortly be launching a range of consultancy services aimed at creating, optimising, and delivering an effective UPC strategy. In the meantime, if you have any questions, please get in touch with your usual Potter Clarkson contact today.

Related News

Potter Clarkson launches dedicated women’s health & femtech team

Potter Clarkson launches dedicated women’s health & femtech team

Drug discovery in space: How microgravity is transforming pharmaceutical innovation

Drug discovery in space: How microgravity is transforming pharmaceutical innovation

EU design law gets a digital upgrade

EU design law gets a digital upgrade

EU AI Act Article 50: New AI transparency rules

EU AI Act Article 50: New AI transparency rules

Priority patent applications for biotech and chemistry startups

Priority patent applications for biotech and chemistry startups

The deal killers investors often find too late: An IP lawyer’s guide to investor readiness

The deal killers investors often find too late: An IP lawyer’s guide to investor readiness

HPV-positive oropharyngeal cancer: prevention to precision treatment

HPV-positive oropharyngeal cancer: prevention to precision treatment

Unlocking the future of cleantech

Unlocking the future of cleantech

See All News
No items found.